T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$2.49B |
| 2 |
Apple
AAPL
|
+$1.65B |
| 3 |
Sherwin-Williams
SHW
|
+$1.5B |
| 4 |
Kenvue
KVUE
|
+$1.4B |
| 5 |
HubSpot
HUBS
|
+$1.4B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$4.49B |
| 2 |
Lam Research
LRCX
|
+$1.45B |
| 3 |
Applied Materials
AMAT
|
+$1.31B |
| 4 |
Fortinet
FTNT
|
+$1.31B |
| 5 |
GE Vernova
GEV
|
+$1.19B |
Sector Composition
| 1 | Technology | 32.36% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.47% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Regal Rexnord
RRX
$9.22B
| $7.11M | ﹤0.01% |
42,857
+2,292
| +6% | +$380K |
|
1202
WPP
WPP
$5.86B
| $7.11M | ﹤0.01% |
+138,909
| New | +$7.11M |
|
1203
Fox Class B
FOX
$25.8B
| $7.05M | ﹤0.01% |
181,653
+4,232
| +2% | +$164K |
|
1204
Coca-Cola Femsa
KOF
$18B
| $7.04M | ﹤0.01% |
79,300
+15,300
| +24% | +$1.36M |
|
|
NARI
1205
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $7.03M | ﹤0.01% |
170,442
-133,591
| -44% | -$5.51M |
|
1206
Grupo Cibest S.A. American Depositary Shares (each representing four (4) Preferred Shares)
CIB
$12.5B
| $7.01M | ﹤0.01% |
223,452
+31,723
| +17% | +$995K |
|
1207
Timken Company
TKR
$5.4B
| $6.97M | ﹤0.01% |
82,671
+2,740
| +3% | +$231K |
|
1208
Hawkins
HWKN
$3.62B
| $6.93M | ﹤0.01% |
54,372
+771
| +1% | +$98.3K |
|
1209
PBF Energy
PBF
$3.18B
| $6.86M | ﹤0.01% |
221,536
-5,765
| -3% | -$178K |
|
|
ORKA
1210
Oruka Therapeutics, Inc. Common Stock
ORKA
$577M
| $6.86M | ﹤0.01% |
+279,648
| New | +$6.86M |
|
|
BERY
1211
DELISTED
Berry Global Group, Inc.
BERY
| $6.83M | ﹤0.01% |
109,379
+3,285
| +3% | +$205K |
|
1212
Spirit AeroSystems
SPR
$4.54B
| $6.78M | ﹤0.01% |
208,476
-8,009,122
| -97% | -$260M |
|
1213
RingCentral
RNG
$2.75B
| $6.77M | ﹤0.01% |
214,007
+157,286
| +277% | +$4.98M |
|
1214
Kemper
KMPR
$3.35B
| $6.76M | ﹤0.01% |
110,353
+5,293
| +5% | +$324K |
|
1215
Brookfield
BN
$101B
| $6.74M | ﹤0.01% |
+126,838
| New | +$6.74M |
|
1216
Corbus Pharmaceuticals
CRBP
$116M
| $6.72M | ﹤0.01% |
325,668
+23,482
| +8% | +$484K |
|
1217
ARS Pharmaceuticals
SPRY
$991M
| $6.71M | ﹤0.01% |
462,519
+446,799
| +2,842% | +$6.48M |
|
1218
Jefferies Financial Group
JEF
$13.7B
| $6.68M | ﹤0.01% |
108,494
+652
| +0.6% | +$40.1K |
|
1219
Korn Ferry
KFY
$3.79B
| $6.66M | ﹤0.01% |
88,450
+6,791
| +8% | +$511K |
|
1220
NETSCOUT
NTCT
$1.8B
| $6.65M | ﹤0.01% |
305,806
+258,005
| +540% | +$5.61M |
|
1221
WisdomTree
WT
$2.11B
| $6.5M | ﹤0.01% |
650,970
-9,099
| -1% | -$90.9K |
|
1222
Steven Madden
SHOO
$2.26B
| $6.5M | ﹤0.01% |
132,709
+4,909
| +4% | +$241K |
|
1223
ScottsMiracle-Gro
SMG
$3.51B
| $6.45M | ﹤0.01% |
74,386
-2,648,024
| -97% | -$230M |
|
1224
NeoGenomics
NEO
$1.03B
| $6.38M | ﹤0.01% |
432,540
-156,054
| -27% | -$2.3M |
|
1225
Unum
UNM
$12.8B
| $6.37M | ﹤0.01% |
107,120
+5,838
| +6% | +$347K |
|